Veeco Instruments INC
Market Movers (8-K)
NASDAQ
Veeco Instruments Inc. announced its first quarter 2026 financial results, reporting a decrease in revenue and net income compared to the prior year, but providing guidance for Q2 and reaffirming full-year 2026 outlook.
Worse than expected
NASDAQ
Veeco Instruments Inc. announced its Q4 and full-year 2025 financial results, showing a year-over-year decline in revenue and net income, but provided optimistic 2026 guidance driven by AI and a pending merger with Axcelis.
Delay expected
NASDAQ
Veeco Instruments Inc. stockholders have approved all proposals related to its pending merger with Axcelis Technologies, Inc., moving closer to a second-half 2026 completion.
NASDAQ
Veeco Instruments provides an update on its merger with Axcelis Technologies, securing key regulatory approvals, but faces a potential $15 million revenue shortfall due to U.S. customs holding two Laser Annealing system shipments to China.
Delay expected
Worse than expected
NASDAQ
Veeco Instruments Inc. has voluntarily supplemented its definitive proxy statement for the Axcelis merger following shareholder lawsuits challenging disclosure adequacy, aiming to avoid litigation delays.
Delay expected
NASDAQ
Veeco Instruments reports Q3 2025 financial results with revenue and earnings declines year-over-year, while advancing its pending merger with Axcelis Technologies.
Better than expected
Quarterly Earnings (10-Q)
NASDAQ
Veeco Instruments Inc. reported a net loss of $0.324 million for the first quarter of 2026, with net sales down 5% year-over-year, while awaiting regulatory approval for its merger with Axcelis Technologies.
Worse than expected
NASDAQ
Veeco Instruments Inc. reported a significant decline in Q3 and year-to-date financial results, with net income down over 50% for the quarter, while progressing with its planned merger with Axcelis Technologies.
Worse than expected
Delay expected
Capital raise
NASDAQ
Veeco Instruments reports a decrease in net sales and profit for Q2 2025, driven by declines in Data Storage and China, despite strong growth in its Semiconductor segment.
Capital raise
Worse than expected
NASDAQ
Veeco Instruments' Q1 2025 net sales decreased by 4% year-over-year, with semiconductor growth partially offsetting declines in data storage and compound semiconductor markets.
Worse than expected
Delay expected
NASDAQ
Veeco Instruments Inc. saw a 4% increase in net sales in Q3 2024, driven by a 26% surge in semiconductor revenue, which offset declines in other markets.
Better than expected
NASDAQ
Veeco Instruments Inc. saw a significant improvement in its second quarter 2024 financial results, driven by growth in the semiconductor market and increased gross margins.
Better than expected
Annual Reports (10-K)
NASDAQ
Veeco Instruments Inc. reported a 7% decline in net sales and a 52% drop in net income for 2025, while advancing its merger with Axcelis Technologies and seeing strong growth in its Semiconductor and Scientific & Other markets.
Worse than expected
Delay expected
NASDAQ
Veeco Instruments Inc. demonstrates year-over-year revenue growth and strategic wins in 2024, driven by the Semiconductor market, while navigating cyclical industry trends and global economic uncertainties.
Worse than expected
NASDAQ
Veeco Instruments Inc. reports its annual results in a 10-K filing, showcasing growth in the semiconductor market and strategic advancements.
Worse than expected
Delay expected
Insider Trading (Form 4)
NASDAQ
SVP of Global Sales & Service Susan Wilkerson sold 15,505.6 shares of Veeco Instruments Inc. common stock.
NASDAQ
Veeco Instruments Director Gordon Hunter sold 16,974 shares of common stock on June 9, 2026.
NASDAQ
Veeco Instruments Director Gordon Hunter sold 6,752 shares of common stock at an average price of $63.78.
NASDAQ
Veeco Instruments CEO William John Miller reported a sale of 50,000 shares of common stock on June 2, 2026, for an average price of $58.62 per share.
NASDAQ
Veeco Instruments Inc. Director Gordon Hunter sold 17,714 shares of common stock at an average price of $61.61.
NASDAQ
Susan Wilkerson, SVP of Global Sales & Service at Veeco Instruments Inc., reported a sale of 35,723 shares of common stock on May 26, 2026.
Proxy Statements (Def-14A)
NASDAQ
Veeco's 2026 proxy statement outlines annual meeting proposals, executive compensation, and the impact of its September 2025 merger agreement with Axcelis Technologies.
Worse than expected
NASDAQ
Axcelis Technologies and Veeco Instruments plan to combine in an all-stock merger of equals, creating a leading semiconductor equipment company.
Delay expected
NASDAQ
Veeco Instruments Inc. is holding its annual meeting on May 9, 2024, and is soliciting stockholder votes on director elections, a stock incentive plan amendment, executive compensation, and auditor ratification.
NASDAQ
Veeco Instruments is holding its 2025 Annual Meeting of Stockholders to vote on the election of directors, an amendment to the Employee Stock Purchase Plan, executive compensation, and the ratification of its accounting firm.
NASDAQ
DEFA14A: Veeco Instruments Inc. to Hold Annual Meeting on May 9, 2024, with Key Proposals on the Agenda
Veeco Instruments Inc. is set to hold its annual meeting on May 9, 2024, featuring proposals including the election of directors, an amendment to the stock incentive plan, executive compensation approval, and ratification of the independent auditor.
NASDAQ
Veeco Instruments is holding its 2024 Annual Meeting of Stockholders to vote on the election of directors, an amendment to the stock incentive plan, executive compensation, and the ratification of its independent auditor.
Schedule 13G - Passive Investments
NASDAQ
Vanguard Capital Management has reported beneficial ownership of 5.12% of Veeco Instruments Inc. common stock as of March 31, 2026.
NASDAQ
Vanguard Portfolio Management has reported a beneficial ownership of 7.79% in Veeco Instruments Inc. common stock as of March 31, 2026.
NASDAQ
The Vanguard Group reports 0% beneficial ownership in Veeco Instruments Inc. following an internal realignment.
NASDAQ
Manulife Financial Corporation and its subsidiaries have filed an amended Schedule 13G, reporting a combined beneficial ownership of 4.24% in Veeco Instruments Inc. common stock.
Worse than expected
NASDAQ
FMR LLC and Abigail P. Johnson have reported a 10.1% beneficial ownership stake in Veeco Instruments Inc. common stock.
NASDAQ
SCHEDULE: Manulife Amends Veeco Instruments Stake
Manulife Financial Corporation and its subsidiaries updated their beneficial ownership of Veeco Instruments Inc. common stock, with Manulife Investment Management (US) LLC holding 5.55%.